Haemonetics Corp/mass (HAE) — Who Owns This Stock? 13F Breakdown (Q2 2026)

HAE ranks #1899 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

HAE is a disclosed holding of Cliff Asness (AQR Capital Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.1% of that fund's own 13F portfolio.

333 institutions disclose a position in HAE, but none treat it as a major bet — even North Peak Capital Management, LLC, its most concentrated holder, allocates just 2.9% of its own portfolio to it.

Wealth Enhancement Advisory Services, LLC has added to its HAE position for two straight quarters, increasing it by $1.0M to reach $1.6M today.

HAE is down 0.5% today, but institutions show net buying of $576.2M this quarter — a divergence between today's price move and the underlying institutional flow.

HAE posted net income of $96.3M over the trailing twelve months, and currently trades at a P/E of 51.8.

• Profitable — net income of $96.3M over the trailing twelve months
• Revenue declined 0.6% year over year
• Net income declined year over year, from $167.7M to $96.3M
• Generated $293.2M in positive operating cash flow
• Current ratio of 2.95x — enough short-term assets to cover short-term liabilities
• Liabilities run x equity — a highly leveraged balance sheet worth noting